Effects of Treatment with Proton Pump Inhibitors in Metabolic Control in Patients with type 2 Diabetes [abstract 2425PO]
What Our Patients Say Exceptional Service
Aronne LJ, Horn DB, le Roux CW, Ho W, Falcon BL, Gomez Valderas E, Das S, Lee CJ, Glass LC, Senyucel C, Dunn JP
In the year since the FDA declared the GLP-1 shortage resolved, there have been these developments: In September 2025, the FDA announced its intent to regulate compounded GLP-s more aggressively
Do not use Wegovy, Ozempic, or Compounded Semaglutide if you or any of your family have ever had a type of thyroid cancer called medullary thyroid carcinoma (MTC), or if you have an endocrine system condition called multiple endocrine neoplasia syndrome type 2 (MEN 2)